Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
National Cancer Institute (NCI)
University of Kentucky
National Cancer Institute (NCI)
Northwestern University
Garden State Cancer Center at the Center for Molecular Medicine and Immunology